Santen Pharm Dividend yield

Santen Pharm is part of Pharmaceuticals and Biotechnology business, which is part of Health Care industry. Santen Pharm is a company from Japan, and his stocks are publicly traded.

Santen Pharm paid a total dividend of 11,160 million JPY last year, for a market value of 668,325 millions (Market Cap 595,436 millions). Dividend per share of Santen Pharm is 27.97 JPY, and his stock market price 1,675.00 JPY.

According to the chart below, where dividend yield is displayed, Santen Pharm has a dividend yield of 1.67%, which is lower than the amount offered by the market average , but bigger than Health Care industry. Dividend yields are similar among companies from the same industry, so it is a positive sign for the company.

In addition, you should compare Santen Pharm dividend yield with other Pharmaceuticals and Biotechnology companies or firms from Japan.

Santen Pharm Dividend Payout

About the ability of Santen Pharm to maintain his current dividend of JPY 27.97 per share, an amount that accounts for 1.67%, we should study its payout ratio both on earnings and on cash-flows (see chart below). Santen Pharm payout on ernings is currently 32.06%, which is lower than the market average and companies of Health Care industry, which are 38.46% and 32.17% respectively. Both figures lead us to believe that there is confidence that Santen Pharmcan maintain his current dividend.

The payout on earnings should be complemented with the payout on cash flow since it is this last amount the one which can be distributed to shareholders. Cash flow per share of Santen Pharm is JPY 100.30 per share, which is higher than the dividend per share paid by the company of JPY 27.97, so the company generates enough cash to maintain his dividend in the future.

The following figure shows payout ratios over earnings and cashflow of Santen Pharm, compared againt world market average, Japan companies, Health Care industry and Pharmaceuticals and Biotechnology sector companies.

Santen Pharm Stock performance

Finally, last moth Santen Pharm showed a return of -3.50% compared to a worldwide 3.99% average, and a 3.09% of Health Care firms. Over the last year, the company obtained a -19.70% versus a worldwide performance of a 6.44%. More detailed information can be seen in the following graph for Japan and Pharmaceuticals and Biotechnology firms.